| Trial ID: | L3923 |
| Source ID: | NCT02351323
|
| Associated Drug: |
Glutamine (Pharmacological Doses)
|
| Title: |
Novel Type 2 Diabetes Mellitus Preventive Therapies
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes
|
| Interventions: |
DRUG: Glutamine (Pharmacological doses)|BEHAVIORAL: Lifestyle change
|
| Outcome Measures: |
Primary: Weight gain, 12-14 weeks | Secondary: Change in A1C, 12-14 weeks
|
| Sponsor/Collaborators: |
Sponsor: Boston Medical Center
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2010-05
|
| Completion Date: |
2014-08
|
| Results First Posted: |
|
| Last Update Posted: |
2015-01-30
|
| Locations: |
Boston Medical Center, Boston, Massachusetts, 02118, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02351323
|
